全文获取类型
收费全文 | 2393306篇 |
免费 | 186127篇 |
国内免费 | 9789篇 |
专业分类
耳鼻咽喉 | 30646篇 |
儿科学 | 78190篇 |
妇产科学 | 65443篇 |
基础医学 | 339465篇 |
口腔科学 | 65910篇 |
临床医学 | 225356篇 |
内科学 | 474338篇 |
皮肤病学 | 52820篇 |
神经病学 | 198509篇 |
特种医学 | 92311篇 |
外国民族医学 | 622篇 |
外科学 | 352285篇 |
综合类 | 55308篇 |
现状与发展 | 3篇 |
一般理论 | 838篇 |
预防医学 | 200644篇 |
眼科学 | 51842篇 |
药学 | 172166篇 |
11篇 | |
中国医学 | 4914篇 |
肿瘤学 | 127601篇 |
出版年
2018年 | 26431篇 |
2017年 | 20374篇 |
2016年 | 23272篇 |
2015年 | 26341篇 |
2014年 | 36569篇 |
2013年 | 55987篇 |
2012年 | 72213篇 |
2011年 | 77254篇 |
2010年 | 46552篇 |
2009年 | 44268篇 |
2008年 | 71236篇 |
2007年 | 75561篇 |
2006年 | 76846篇 |
2005年 | 74264篇 |
2004年 | 70802篇 |
2003年 | 68138篇 |
2002年 | 65351篇 |
2001年 | 109608篇 |
2000年 | 112701篇 |
1999年 | 94592篇 |
1998年 | 28204篇 |
1997年 | 25352篇 |
1996年 | 25947篇 |
1995年 | 25546篇 |
1994年 | 23928篇 |
1993年 | 22426篇 |
1992年 | 77368篇 |
1991年 | 75530篇 |
1990年 | 72888篇 |
1989年 | 69259篇 |
1988年 | 64376篇 |
1987年 | 63094篇 |
1986年 | 59935篇 |
1985年 | 57611篇 |
1984年 | 43901篇 |
1983年 | 37024篇 |
1982年 | 22912篇 |
1981年 | 20462篇 |
1980年 | 19157篇 |
1979年 | 39709篇 |
1978年 | 28769篇 |
1977年 | 23897篇 |
1976年 | 22736篇 |
1975年 | 23473篇 |
1974年 | 28126篇 |
1973年 | 27179篇 |
1972年 | 25117篇 |
1971年 | 23276篇 |
1970年 | 21393篇 |
1969年 | 19809篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Participation of angiotensin II in learning and memory. III. Interactions of angiotensin II with GABAergic drugs 总被引:1,自引:0,他引:1
D Yonkov V Georgiev T Kambourova M Opitz 《Methods and findings in experimental and clinical pharmacology》1987,9(4):205-208
The experiments were carried out on male albino rats trained and tested for retention (24 hr later) in a shuttle-box. Angiotensin II (AT II) 0.10 micrograms intracerebroventricularly (i.c.v.), gamma-aminobutyric acid (GABA) 100 micrograms i.c.v., bicuculline 0.5 and 1.0 mg/kg intraperitoneally (i.p.), and picrotoxin 0.5 and 1.0 mg/kg i.p. administered independently or in combinations immediately after training. AT II was found to improve retention. GABA also facilitated retention. Combination of AT II + GABA potentiated the memory-improving effect of AT II. Bicuculline and picrotoxin at a dose of 0.5 mg/kg did not affect retention, while at a dose of 1.0 mg/kg they improved it. Combinations of AT II + bicuculline (0.5 mg/kg) and AT II + picrotoxin (0.5 mg/kg) abolished the retention-improving effect of AT II. Bicuculline (0.5 mg/kg) or picrotoxin (0.5 mg/kg) abolished the retention-facilitating effect of the combination of AT II + GABA as well as the potentiating action of GABA on the memory effect of AT II. These results suggest the participation of GABAergic transmission in the CNS in the mechanisms of the long-term memory-improving effect of AT II. 相似文献
993.
Experience with the 'skew flap' below-knee amputation 总被引:3,自引:0,他引:3
A review of 353 lower limb amputations over the last 7 years has been performed to assess the results of the skew flap myoplastic below-knee amputation which was introduced in April 1983 because of reported advantages in terms of wound healing and earlier ambulation. Comparing the first 3 1/2 year period with the second, the total number of amputations decreased by 31 per cent. The number of above-knee amputations remained similar in the two periods (82,62), whilst the number of Gritti-Stokes amputations fell from 79 to 21 (0.001 greater than P greater than 0.01). The proportion of below-knee (BK) amputations increased from 50 (23.7 per cent) to 59 (41.5 per cent) (0.01 greater than P greater than 0.025). The groups were comparable in terms of previous vascular surgery and co-existing medical conditions. The time to full stump healing was significantly shorter in the skew flap group compared with the earlier Burgess type BK amputation (P = 0.001), and there was a trend to fewer stump failures in the skew flap group. We therefore feel that the skew flap amputation gives superior results to the Burgess BK amputation in terms of healing and a lower complication rate, allowing a higher proportion of BK amputations to be performed. A prospective randomized trial of the two techniques is in hand to determine the accuracy of this hypothesis. 相似文献
994.
Ambient light affects pulse oximeters 总被引:1,自引:0,他引:1
995.
996.
997.
Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease 总被引:1,自引:0,他引:1
K Steingold D De Ziegler M Cedars D R Meldrum J K Lu H L Judd R J Chang 《The Journal of clinical endocrinology and metabolism》1987,65(4):773-778
Previously, we reported that short term administration of a highly potent GnRH agonist (GnRHa) for 1 month to patients with polycystic ovarian disease (PCO) resulted in complete suppression of ovarian steroidogenesis without measurable effects on adrenal steroid production. This new study was designed to evaluate the effects of long term GnRHa administration in PCO patients with respect to their hormone secretion patterns and clinical responses. Eight PCO patients and 10 ovulatory women with endometriosis were treated daily with sc injections of [D-His6-(imBzl]),Pro9-NEt]GnRH (GnRHa; 100 micrograms) for 6 months. Their results were compared to hormone values in 8 women who had undergone bilateral oophorectomies. In response to GnRHa, PCO and ovulatory women had rises of serum LH at 1 month, after which it gradually declined to baseline. In both groups FSH secretion was suppressed throughout treatment. Serum estradiol, estrone, progesterone, 17-hydroxyprogesterone, androstenedione, and testosterone levels markedly decreased to values found in oophorectomized women by 1 month and remained low thereafter. In contrast, serum pregnenolone and 17-hydroxypregnenolone were partially suppressed, and dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol levels did not change. Clinically, hyperplastic endometrial histology in three PCO patients reverted to an inactive pattern, and proliferative endometrium in two other PCO patients became inactive in one and did not change in the other. Regression of proliferative endometrial histology occurred in all ovulatory women. Vaginal bleeding occurred in all women studied during the first month of GnRHa administration, after which all but one PCO patient became amenorrheic. Hot flashes were noted by all ovulatory women and by four of eight PCO patients. All PCO patients noted subjective reduction of skin oiliness, and five had decreased hair growth. We conclude that in premenopausal women: 1) chronic GnRHa administration results in apparently complete persistent suppression of ovarian steroid secretion; 2) adrenal steroid secretion is not influenced directly or indirectly; and 3) its use may be helpful in the treatment of endometrial hyperplasia and ovarian androgen excess in women with PCO. 相似文献
998.
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease 总被引:1,自引:0,他引:1
Positron emission tomography (PET) with fluorodeoxyglucose (FDG), magnetic resonance imaging (MRI), and CT were carried out in a patient with Alzheimer's disease 16 months before he died. At autopsy, the gross appearance of the brain correlated with MRI and CT, which showed some regional atrophy. These were much less revealing than PET, which correlated with microscopic findings of neuronal loss and proliferation of glia. In areas of moderately impaired local cerebral metabolic rate of glucose, as revealed by reduced FDG uptake, there was some gliosis, primarily around the numerous senile plaques. In areas of severe metabolic impairment, there was a profound loss of neurons, extensive gliosis, and a diminished appearance of plaques. PET-FDG is a better measure of the severity of Alzheimer's disease than MRI or CT, because it reflects the degree of neuronal pathology. 相似文献
999.
1000.
G H Ballantyne M J Zdon D E Schafer G R Fratesi J R Roberts M Tyshkov I M Modlin 《Annals of surgery》1986,204(5):559-565
The cellular mechanisms by which pepsinogen (PNG) secretion is controlled are not understood. The aim of this study was to explore whether modulation of PNG secretion is mediated by cAMP or calcium-calmodulin (C-C). PNG secretion in isolated rabbit gastric fundic glands (IGG) was tested, using agents believed to act via cAMP or C-C. IGG were stimulated for 30 minutes with histamine (H) 10(-5) M, isoproterenol (I) 10(-5) M, carbachol (C) 10(-5) M, cholecystokinin-octapeptide (CCK-8) 10(-7) M, forskolin (F) 10(-5) M, 8 bromo-cAMP (8B) 10(-3) M, and A23187 (A) 10(-6) M. PNG levels were determined by spectrophotometric assay of hemoglobin digestion products. PNG amounts secreted were (mean per cent above basal levels of total IGG PNG units +/- SEM): H, -0.02 +/- 0.30%; I, 3.5 +/- 0.9%; C, 5.1 +/- 2.2%; CCK-8, 5.3 +/- 1.5%; F, 10.6 +/- 3.8%; 8B, 13.8 +/- 4.5%; A, 2.1 +/- 1.1%. All secretagogues except H stimulated PNG release significantly above basal levels (p less than 0.05). A primary histaminergic mechanism for pepsinogen secretion is unlikely. Since two other adenylate cyclase activators, isoproterenol and forskolin and the 3':5'-cyclic adenosine monophosphate analog 8-bromo cAMP stimulated pepsinogen secretion, cAMP-dependence is probable. Since carbachol, CCK-8, and A23187, which are believed to act via calcium-calmodulin, also stimulated pepsinogen secretion, this system, too, presumably plays a substantial role. Thus the data support a dual 3':5'-cyclic adenosine monophosphate/calcium-calmodulin modulation of pepsinogen secretion. 相似文献